ID   KKU-M055/46
AC   CVCL_C1L4
SY   M055/46
DR   Wikidata; Q114311817
RX   PubMed=18714155;
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M258 ! KKU-M055
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=18714155; DOI=10.1159/000151541;
RA   Namwat N., Amimanan P., Loilome W., Jearanaikoon P., Sripa B.,
RA   Bhudhisawasdi V., Tassaneeyakul W.;
RT   "Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell
RT   lines.";
RL   Chemotherapy 54:343-351(2008).
//